Found: 20
Select item for more details and to access through your institution.
Endocrine therapy initiation among women with stage I–III invasive, hormone receptor-positive breast cancer from 2001–2016.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 203, doi. 10.1007/s10549-022-06561-z
- By:
- Publication type:
- Article
Common founder BRCA2 pathogenic variants and breast cancer characteristics in Ethiopian Jews.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 217, doi. 10.1007/s10549-022-06557-9
- By:
- Publication type:
- Article
Validation sentinel lymph node biopsy study in cN0 axilla using low-cost dual dye technique: potential solution for resource poor settings.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 105, doi. 10.1007/s10549-022-06556-w
- By:
- Publication type:
- Article
The association between meat and fish intake by preparation methods and breast cancer in the Carolina Breast Cancer Study (CBCS).
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 187, doi. 10.1007/s10549-022-06555-x
- By:
- Publication type:
- Article
Radiotherapy, chemotherapy, and heart disease.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 111, doi. 10.1007/s10549-022-06553-z
- By:
- Publication type:
- Article
High RAD51 gene expression is associated with aggressive biology and with poor survival in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 49, doi. 10.1007/s10549-022-06552-0
- By:
- Publication type:
- Article
Trends in surgery and adjuvant treatment for early-stage breast cancer: a population-based study in Queensland, Australia.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 175, doi. 10.1007/s10549-022-06551-1
- By:
- Publication type:
- Article
Sexual activity and functioning in long-term breast cancer survivors; exploring associated factors in a nationwide survey.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 139, doi. 10.1007/s10549-022-06544-0
- By:
- Publication type:
- Article
Concordance between core needle biopsy and surgical excision for breast cancer tumor grade and biomarkers.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 151, doi. 10.1007/s10549-022-06548-w
- By:
- Publication type:
- Article
Emerging strategies for TNBC with early clinical data: new chemoimmunotherapy strategies.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 21, doi. 10.1007/s10549-022-06547-x
- By:
- Publication type:
- Article
Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 37, doi. 10.1007/s10549-022-06545-z
- By:
- Publication type:
- Article
Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 161, doi. 10.1007/s10549-022-06550-2
- By:
- Publication type:
- Article
Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 95, doi. 10.1007/s10549-022-06543-1
- By:
- Publication type:
- Article
Comment on "Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis".
- Published in:
- 2022
- By:
- Publication type:
- Letter
Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a CancerLinQ® study.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 83, doi. 10.1007/s10549-022-06541-3
- By:
- Publication type:
- Article
Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 225, doi. 10.1007/s10549-022-06528-0
- By:
- Publication type:
- Article
A Canadian national guideline on the neoadjuvant treatment of invasive breast cancer, including patient assessment, systemic therapy, and local management principles.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 1, doi. 10.1007/s10549-022-06522-6
- By:
- Publication type:
- Article
Multi-center evaluation of artificial intelligent imaging and clinical models for predicting neoadjuvant chemotherapy response in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 121, doi. 10.1007/s10549-022-06521-7
- By:
- Publication type:
- Article
Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 1, p. 65, doi. 10.1007/s10549-022-06514-6
- By:
- Publication type:
- Article